Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Coral Gables, FL
SEC filing record 1 source field available
Fiscal year end
31 December
RELMADA THERAPEUTICS, INC. has filed 600 SEC EDGAR filings since 13 Nov 2012

SEC filing history

Showing 426-450 of 600 matching filings.

Per page
25
Current page
18
8-K File 000-55347

CURRENT REPORT

Filing date
10 Dec 2018
Reporting date
05 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-55347

QUARTERLY REPORT

Filing date
13 Nov 2018
Reporting date
30 Sep 2018
Next action
Verify source filing
D/A File 021-324029

D/A filing

Filing date
13 Nov 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-55347

CURRENT REPORT

Filing date
08 Nov 2018
Reporting date
02 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-207248

AMENDMENT NO. 1 TO FORM S-3

Filing date
23 Oct 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-324029

D filing

Filing date
22 Oct 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
19 Oct 2018
Reporting date
12 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-55347

CURRENT REPORT

Filing date
18 Oct 2018
Reporting date
12 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-55347

ANNUAL REPORT

Filing date
28 Sep 2018
Reporting date
30 Jun 2018
Next action
Verify source filing
8-K File 000-55347

CURRENT REPORT

Filing date
17 Aug 2018
Reporting date
17 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-224920

REGISTRATION STATEMENT

Filing date
14 May 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-55347

QUARTERLY REPORT

Filing date
14 May 2018
Reporting date
31 Mar 2018
Next action
Verify source filing
8-K File 000-55347

CURRENT REPORT

Filing date
05 Apr 2018
Reporting date
04 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
03 Apr 2018
Reporting date
02 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-55347

CURRENT REPORT

Filing date
02 Apr 2018
Reporting date
02 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-55347

QUARTERLY REPORT

Filing date
12 Feb 2018
Reporting date
31 Dec 2017
Next action
Verify source filing
8-K File 000-55347

CURRENT REPORT

Filing date
05 Feb 2018
Reporting date
02 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-55347

CURRENT REPORT

Filing date
19 Jan 2018
Reporting date
16 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-55347

DEFINITIVE PROXY STATEMENT

Filing date
15 Dec 2017
Reporting date
18 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-55347

QUARTERLY REPORT

Filing date
14 Nov 2017
Reporting date
30 Sep 2017
Next action
Verify source filing
SC 13G File 005-88207

SCHEDULE 13G

Filing date
31 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
23 Oct 2017
Reporting date
20 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
23 Oct 2017
Reporting date
20 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
23 Oct 2017
Reporting date
20 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
23 Oct 2017
Reporting date
20 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .